Shifting from the treat-to-target to the early highly effective treatment approach in patients with multiple sclerosis – real-world evidence from Germany
Article in Therapeutic Advances in Neurological Disorders (January 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies
Article in Therapeutic Advances in Neurological Disorders (January 2024)
Chapter 5 Disease-modifying therapies Current landscape and emerging approaches
Book chapter (January 2024)